Itoh K - Search Results

1

[Acquired tumor "robustness" in the case of prostate cancer].

Homma S, Noguchi M, Sato Y, Maeda Y, Shomura H, Komohara Y, Mine T, Harada M, Yamada A, Todo S, Itoh K. Homma S, et al. Among authors: itoh k. Gan To Kagaku Ryoho. 2006 Nov;33(12):1748-50. Gan To Kagaku Ryoho. 2006. PMID: 17212095 Japanese.

2

Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients.

Tanaka K, Harashima N, Niiya F, Miyagi Y, Hida N, Ochi M, Imai N, Harada M, Itoh K, Shichijo S. Tanaka K, et al. Among authors: itoh k. Jpn J Cancer Res. 2002 Feb;93(2):198-208. doi: 10.1111/j.1349-7006.2002.tb01259.x. Jpn J Cancer Res. 2002. PMID: 11856484 Free PMC article.

3

Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer.

Suzuki N, Maeda Y, Tanaka S, Hida N, Mine T, Yamamoto K, Oka M, Itoh K. Suzuki N, et al. Among authors: itoh k. Int J Cancer. 2002 Mar 1;98(1):45-50. doi: 10.1002/ijc.10145. Int J Cancer. 2002. PMID: 11857384

4

Expression of tumor rejection antigens in colorectal carcinomas.

Sasatomi T, Suefuji Y, Matsunaga K, Yamana H, Miyagi Y, Araki Y, Ogata Y, Itoh K, Shirouzu K. Sasatomi T, et al. Among authors: itoh k. Cancer. 2002 Mar 15;94(6):1636-41. doi: 10.1002/cncr.10421. Cancer. 2002. PMID: 11920522 Free article.

5

Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosis.

Yutani S, Tanaka M, Mutsumoto H, Imai N, Sata M, Shichijo S, Harada M, Itoh K. Yutani S, et al. Among authors: itoh k. Jpn J Cancer Res. 2002 Apr;93(4):453-8. doi: 10.1111/j.1349-7006.2002.tb01277.x. Jpn J Cancer Res. 2002. PMID: 11985796 Free PMC article.

6

Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients.

Maeda Y, Ito M, Harashima N, Nakatsura T, Hida N, Imai N, Sato Y, Shichijo S, Todo S, Itoh K. Maeda Y, et al. Among authors: itoh k. Int J Cancer. 2002 May 20;99(3):409-17. doi: 10.1002/ijc.10377. Int J Cancer. 2002. PMID: 11992410

7

Measurement of interferon-gamma by high-throughput fluorometric microvolume assay technology system.

Komatsu N, Shichijo S, Maeda Y, Itoh K. Komatsu N, et al. Among authors: itoh k. J Immunol Methods. 2002 May 1;263(1-2):169-76. doi: 10.1016/s0022-1759(02)00037-6. J Immunol Methods. 2002. PMID: 12009212

8

A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation.

Hida N, Maeda Y, Katagiri K, Takasu H, Harada M, Itoh K. Hida N, et al. Among authors: itoh k. Cancer Immunol Immunother. 2002 Jun;51(4):219-28. doi: 10.1007/s00262-002-0273-7. Epub 2002 Apr 6. Cancer Immunol Immunother. 2002. PMID: 12012109 Free PMC article.

9

Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer.

Gohara R, Imai N, Rikimaru T, Yamada A, Hida N, Ichiki M, Kawamoto M, Matsunaga K, Ashihara J, Yano S, Tamura M, Ohkouchi S, Yamana H, Oizumi K, Itoh K. Gohara R, et al. Among authors: itoh k. J Immunother. 2002 Sep-Oct;25(5):439-44. doi: 10.1097/00002371-200209000-00008. J Immunother. 2002. PMID: 12218782 Clinical Trial.

10

Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B*4601-restricted and tumor cell-reactive CTLs at tumor site.

Azuma K, Shichijo S, Maeda Y, Nakatsura T, Nonaka Y, Fujii T, Koike K, Itoh K. Azuma K, et al. Among authors: itoh k. Cancer Res. 2003 Feb 15;63(4):854-8. Cancer Res. 2003. PMID: 12591737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,001 results

Search Page

Filters